Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Identification of an adenylyl cyclase inhibitor for treating neuropathic and inflammatory pain.

Wang H, Xu H, Wu LJ, Kim SS, Chen T, Koga K, Descalzi G, Gong B, Vadakkan KI, Zhang X, Kaang BK, Zhuo M.

Sci Transl Med. 2011 Jan 12;3(65):65ra3. doi: 10.1126/scitranslmed.3001269.

2.

Targeting neuronal adenylyl cyclase for the treatment of chronic pain.

Zhuo M.

Drug Discov Today. 2012 Jun;17(11-12):573-82. doi: 10.1016/j.drudis.2012.01.009. Epub 2012 Jan 26. Review.

PMID:
22405897
3.

Elucidation of pathophysiology and treatment of neuropathic pain.

Vranken JH.

Cent Nerv Syst Agents Med Chem. 2012 Dec;12(4):304-14. Review.

PMID:
23033930
4.

Uncovering new pharmacological targets to treat neuropathic pain by understanding how the organism reacts to nerve injury.

Martin YB, Herradón G, Ezquerra L.

Curr Pharm Des. 2011;17(5):434-48. Review.

PMID:
21375486
5.

[Contribution of primary sensory neurons and spinal glial cells to pathomechanisms of neuropathic pain].

Obata K, Noguchi K.

Brain Nerve. 2008 May;60(5):483-92. Review. Japanese.

PMID:
18516970
6.

Neuropathic pain: models and mechanisms.

Jarvis MF, Boyce-Rustay JM.

Curr Pharm Des. 2009;15(15):1711-6. Review.

PMID:
19442185
7.

Research progress of mechanisms and drug therapy for neuropathic pain.

Yan YY, Li CY, Zhou L, Ao LY, Fang WR, Li YM.

Life Sci. 2017 Dec 1;190:68-77. doi: 10.1016/j.lfs.2017.09.033. Epub 2017 Sep 28. Review.

PMID:
28964813
8.

Pharmacologic treatment of neuropathic pain.

Wallace MS.

Curr Pain Headache Rep. 2001 Apr;5(2):138-50. Review.

PMID:
11252148
9.

Pain-relieving prospects for adenosine receptors and ectonucleotidases.

Zylka MJ.

Trends Mol Med. 2011 Apr;17(4):188-96. doi: 10.1016/j.molmed.2010.12.006. Epub 2011 Jan 13. Review.

10.

Translational investigation and treatment of neuropathic pain.

Xu B, Descalzi G, Ye HR, Zhuo M, Wang YW.

Mol Pain. 2012 Mar 9;8:15. doi: 10.1186/1744-8069-8-15. Review.

11.

Recent trends in neuropathic pain patents.

Maia RD.

Expert Opin Ther Pat. 2017 May;27(5):539-546. doi: 10.1080/13543776.2017.1273349. Epub 2016 Dec 28. Review.

PMID:
27998196
12.

Strategies for finding new pharmacological targets for neuropathic pain.

Devor M.

Curr Pain Headache Rep. 2004 Jun;8(3):187-91. Review.

PMID:
15115636
13.

An overview of animal models of pain: disease models and outcome measures.

Gregory NS, Harris AL, Robinson CR, Dougherty PM, Fuchs PN, Sluka KA.

J Pain. 2013 Nov;14(11):1255-69. doi: 10.1016/j.jpain.2013.06.008. Epub 2013 Sep 12. Review.

14.

Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain.

Percie du Sert N, Rice AS.

Br J Pharmacol. 2014 Jun;171(12):2951-63. doi: 10.1111/bph.12645. Review.

15.

New Pharmacological Approaches Using Polyphenols on the Physiopathology of Neuropathic Pain.

Boadas-Vaello P, Vela JM, Verdu E.

Curr Drug Targets. 2017;18(2):160-173. doi: 10.2174/1389450117666160527142423. Review.

PMID:
27231108
16.

Neuronal mechanism for neuropathic pain.

Zhuo M.

Mol Pain. 2007 Jun 6;3:14. Review.

17.

The neurobiology of skeletal pain.

Mantyh PW.

Eur J Neurosci. 2014 Feb;39(3):508-19. doi: 10.1111/ejn.12462. Review.

18.

Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm.

Taneja A, Della Pasqua O, Danhof M.

Eur J Clin Pharmacol. 2017 Oct;73(10):1219-1236. doi: 10.1007/s00228-017-2301-8. Epub 2017 Sep 11. Review.

19.

Emerging Relationships between Exercise, Sensory Nerves, and Neuropathic Pain.

Cooper MA, Kluding PM, Wright DE.

Front Neurosci. 2016 Aug 23;10:372. doi: 10.3389/fnins.2016.00372. eCollection 2016. Review.

Supplemental Content

Support Center